CGEM ▲ +0.6% - Cullinan Therapeutics, Inc.
$CGEM - Cullinan Therapeutics Announces Presentations for CLN-049, a FLT3 T Cell Engager, and Velinotamig, a BCMA T Cell Engager, at the 68th ASH Annual Meeting
04-NOV-2026 09:14 AM ET
Share this post
More filings for $CGEM
CGEM ▼ -0.1% - Cullinan Therapeutics, Inc.Oct 27, 2026CGEM ▲ +0.2% - Cullinan Therapeutics, Inc.Oct 8, 2026CGEM ▼ -5.3% - Cullinan Therapeutics, Inc.Oct 1, 2026CGEM ▼ -0.5% - Cullinan Therapeutics, Inc.Sep 24, 2026CGEM ▼ -0.4% - Cullinan Therapeutics, Inc.Sep 21, 2026CGEM ▲ +0.8% - Cullinan Therapeutics, Inc.Sep 14, 2026
View full $CGEM filing history →💬 Comments
Loading comments…
Leave a comment